1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death
about
Metabolomics in the studies of islet autoimmunity and type 1 diabetes1H NMR metabonomics indicates continued metabolic changes and sexual dimorphism post-parasite clearance in self-limiting murine malaria modelA (1)H NMR-Based Metabonomic Investigation of Time-Related Metabolic Trajectories of the Plasma, Urine and Liver Extracts of Hyperlipidemic HamstersAlterations of urinary metabolite profile in model diabetic nephropathy.Statistical methods for the analysis of high-throughput metabolomics data.Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetesMetabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing mapsInsulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approachAlterations in urine, serum and brain metabolomic profiles exhibit sexual dimorphism during malaria disease progression.Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traitsA family based tailored counselling to increase non-exercise physical activity in adults with a sedentary job and physical activity in their young children: design and methods of a year-long randomized controlled trial.Advances in NMR-based biofluid analysis and metabolite profilingNavigating the human metabolome for biomarker identification and design of pharmaceutical molecules.The metabolic profile of long-lived Drosophila melanogasterCalcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis.A practical approach to detect unique metabolic patterns for personalized medicineLiver Metabolic Alterations and Changes in Host Intercompartmental Metabolic Correlation during Progression of MalariaAnalytical methods in untargeted metabolomics: state of the art in 2015.Multivariate modelling with (1)H NMR of pleural effusion in murine cerebral malariaSphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus.DanHong injection dose-dependently varies amino acid metabolites and metabolic pathways in the treatment of rats with cerebral ischemia.Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.Clinical metabolomics paves the way towards future healthcare strategies.Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetesNetwork of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane Study).Metabolomics applied to diabetes research: moving from information to knowledgeIntestinal ischemia/reperfusion injury: defining the role of the gut microbiome.¹H NMR-based metabonomics for investigating diabetes.Monitoring healthy metabolic trajectories with nutritional metabonomics.Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence.Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy.Self organising maps for visualising and modellingQuantitative high-throughput metabolomics: a new era in epidemiology and genetics.Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling.Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes.Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study.
P2860
Q27023040-A0A770E1-C862-47F0-8F60-A59E133F28E3Q27313337-99621A45-D6D2-490C-A090-D651FB9D7BAFQ28534338-32D5EBB8-5BBC-4DAC-AECE-8443E223F359Q30369623-32DBA541-F841-4313-8FC4-0158A9E877FCQ30790493-D1FF95FF-42E9-4572-A7C3-F53C9CCAFE9AQ30982692-E1AC3A9C-F92C-43C8-B66E-47783DFFBDFCQ33389830-2CE8FF7F-099D-4F9E-A755-945B3213BB5EQ33577893-41230332-9EB7-4930-8E77-DE0831764646Q33728538-53F71A59-04AB-442F-8D75-88085A31A3D9Q33864525-95DB51DA-E0D6-49E9-A944-8E1D46EC043BQ33970039-335A253D-2F0F-4C00-B161-19294AB10A1FQ34106961-51656799-2272-40C1-805A-FD9E79FCDC86Q34109340-626428A5-3A8C-4D11-AA2E-804FC99FB058Q34170091-34960342-5B75-48E1-9DD7-5F2C6B57753AQ34460421-582B633B-D68E-4278-813F-1E3F5654C22CQ34640062-120FB741-CA07-41D5-85D3-D82730F8EA5CQ34754691-603B077A-3388-4575-9BD9-56012B032D14Q35101615-15A749F3-A546-4C22-BF80-3459D0B4113DQ35149924-665B2250-D24D-4A44-AF6D-BFD8945C4357Q35586924-2D455C6D-95D2-4265-9D5E-DC95F518F931Q35957661-99826639-34DC-422A-8378-21E7048CFF2FQ36063502-CF571FC0-C863-4E79-8CCA-25C5453806B2Q36123968-5297B867-5CCF-4510-91FC-B97DBA74CCB8Q36355894-085E1819-6CAC-40C6-A57E-7F3AFAFA554AQ36620171-C2D8C1FC-8B96-46E5-B1C4-BC57E4320BABQ36842641-F3D97851-F9B8-4CEC-9D7A-DB6BA7C8A25CQ37392018-281BCB7B-064D-4303-9E92-90DDC7FD2296Q37400761-BA42E966-DF9E-4ADB-98CF-FCC4B3AF33CFQ37755158-0BCA3F4C-3FC5-4ADF-8904-6F0C97338F15Q37855850-8789C665-0FC0-487A-85ED-74E1E7AD7D5CQ37976685-293DD048-F0CB-4FE6-8A05-2C90AF303A55Q40403746-E4C46452-BCCE-4EDA-9EA0-57491171FE88Q40616407-7CE3D3BB-6738-4C94-B61C-BD8D1052B707Q41505208-5156232A-4C1B-48C8-A60B-CF830849D72DQ41807425-44D0D18A-3D16-47FA-AE60-E1775112F9FCQ41997395-333CDA65-7303-456B-AA70-AA1990BBE30CQ42960221-A698F335-6557-4795-B90E-72E878E04B81Q43187905-05ADC23E-6644-49B7-8397-FE9D2F39B857Q44739256-9D2F3DA3-94F7-4C12-A846-7BD879A52826Q45145247-7D7329EC-06F3-4A1B-BFB6-83FCFBFD8D1D
P2860
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
1H NMR metabonomics approach t ...... plications and premature death
@ast
1H NMR metabonomics approach t ...... plications and premature death
@en
type
label
1H NMR metabonomics approach t ...... plications and premature death
@ast
1H NMR metabonomics approach t ...... plications and premature death
@en
prefLabel
1H NMR metabonomics approach t ...... plications and premature death
@ast
1H NMR metabonomics approach t ...... plications and premature death
@en
P2093
P2860
P50
P356
P1476
1H NMR metabonomics approach t ...... plications and premature death
@en
P2093
Kimmo Kaski
Maija Parkkonen
Pasi Soininen
Petri Ingman
P2860
P356
10.1038/MSB4100205
P577
2008-02-12T00:00:00Z